Found: 11
Select item for more details and to access through your institution.
Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutations.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66505-z
- By:
- Publication type:
- Article
Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36729-0
- By:
- Publication type:
- Article
Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands.
- Published in:
- ChemMedChem, 2022, v. 17, n. 9, p. 1, doi. 10.1002/cmdc.202200058
- By:
- Publication type:
- Article
Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors.
- Published in:
- Molecules, 2021, v. 26, n. 19, p. 5782, doi. 10.3390/molecules26195782
- By:
- Publication type:
- Article
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84733-5
- By:
- Publication type:
- Article
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-20900-6
- By:
- Publication type:
- Article
Comparison of Rapid Antigen Tests for COVID-19.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 12, p. 1420, doi. 10.3390/v12121420
- By:
- Publication type:
- Article
Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65993-z
- By:
- Publication type:
- Article
Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro.
- Published in:
- Frontiers in Microbiology, 2018, p. N.PAG, doi. 10.3389/fmicb.2018.02022
- By:
- Publication type:
- Article
Front Cover: Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants (ChemMedChem 8/2018).
- Published in:
- ChemMedChem, 2018, v. 13, n. 8, p. 762, doi. 10.1002/cmdc.201800226
- By:
- Publication type:
- Article
Design of Highly Potent, Dual‐Acting and Central‐Nervous‐System‐Penetrating HIV‐1 Protease Inhibitors with Excellent Potency against Multidrug‐Resistant HIV‐1 Variants.
- Published in:
- ChemMedChem, 2018, v. 13, n. 8, p. 803, doi. 10.1002/cmdc.201700824
- By:
- Publication type:
- Article